European Pharma Looks Speed Up Reimbursement Via Revisions To EU Transparency Policy
Executive Summary
The European Commission's "Transparency Directive" on drug reimbursement and pricing should be revised to permit companies to submit reimbursement data sooner to regulatory authorities, and thus receive reimbursement decisions earlier, the European Federation of Pharmaceutical Industries and Associations is recommending.